[go: up one dir, main page]

AR029305A1 - Benzolsulfonilureas y -tioureas 2,5-sustituidas, procedimiento para su preparacion, y preparados farmaceuticos que las contienen - Google Patents

Benzolsulfonilureas y -tioureas 2,5-sustituidas, procedimiento para su preparacion, y preparados farmaceuticos que las contienen

Info

Publication number
AR029305A1
AR029305A1 ARP990103448A ARP990103448A AR029305A1 AR 029305 A1 AR029305 A1 AR 029305A1 AR P990103448 A ARP990103448 A AR P990103448A AR P990103448 A ARP990103448 A AR P990103448A AR 029305 A1 AR029305 A1 AR 029305A1
Authority
AR
Argentina
Prior art keywords
carbon atoms
alkyl
phenyl
substituted
alkoxy
Prior art date
Application number
ARP990103448A
Other languages
English (en)
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Publication of AR029305A1 publication Critical patent/AR029305A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36Radicals substituted by singly-bound nitrogen atoms
    • C07D213/40Acylated substituent nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/50Compounds containing any of the groups, X being a hetero atom, Y being any atom
    • C07C311/52Y being a hetero atom
    • C07C311/54Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea
    • C07C311/57Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea having sulfur atoms of the sulfonylurea groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/58Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea having sulfur atoms of the sulfonylurea groups bound to carbon atoms of six-membered aromatic rings having nitrogen atoms of the sulfonylurea groups bound to hydrogen atoms or to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00Sulfones; Sulfoxides
    • C07C317/26Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C317/32Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/64Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and sulfur atoms, not being part of thio groups, bound to the same carbon skeleton
    • C07C323/67Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and sulfur atoms, not being part of thio groups, bound to the same carbon skeleton containing sulfur atoms of sulfonamide groups, bound to the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/40Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of thiourea or isothiourea groups further bound to other hetero atoms
    • C07C335/42Sulfonylthioureas; Sulfonylisothioureas
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
  • Pyridine Compounds (AREA)

Abstract

Benzolsulfonilureas y û tioureas 2,5 û sustituidas, que son valiosas sustancias activas como medicamentos de la formula general (1) en la cual X representa oxígeno o azufre; Y representa û(CR(5)2)n-; R(1) representa: 1) fenilo, sin sustituir o sustituido por uno o dos sustituyentes, iguales o diferentes entre sí, seleccionados de la serie constituida por: halogeno, alquilo de 1 a 4 átomos de carbono, alcoxi de 1 a 4 átomos de carbono, -S(O)m-(C1-4)- alquilo, fenilo, amino, hidroxi, nitro, trifluormetilo, ciano, hidroxi, carbonilo, carbamoílo, (C1-4)- alcoxi carbonilo y formilo: o 2) naftilo; o 3) heteroarilo monocíclico o bicíclico con uno o dos heteroátomos de anillo, iguales o diferentes entre sí, tomados de la serie consistente en: oxígeno, azufre y nitrogeno; o 4) ûS(O)m ûfenilo; o 5) alquenilo de 2 a 5 átomos de carbono, sin sustituir o sustituido por un radical tomado de la siguiente serie: fenilo, ciano, hidroxi carbonilo y (C1-4)- alcoxi carbonilo; o 6) alquilo de 2 a 5 átomos de carbono, sin sustituir o sustituido por un radical de la serie fenilo y alcoxi de 1 a 4 átomos de carbono; R(2) representa hidrogeno o alquilo de 1 a 3 átomos de carbono; R(3) y R(4), independientemente entre sí, representan hidrogeno, halogeno o alcoxi de 1 a 4 átomos de carbono; los radicales R(5), todos ellos independientemente entre sí, iguales o diferentes entre sí, representan hidrogeno o alquilo de 1 a 3 átomos de carbono; m representa 0, 1 o 2; n representa 1,2,3 o 4; en todas sus formas estereoisoméricas y mezclas de las mismas en todas las proporciones y sus sales fisiologicamente aceptables; procedimiento para la preparacion de los compuestos de la formula 1 y preparado farmacéutico que los contienen. Los compuestos de la formula 1 tienen un efecto inhibidor sobre los canales de potasio sensibles al ATP y son adecuados por ejemplo para el tratamiento de los trastornos del sistema cardiocirculatorio, en especial para el tratamiento de las arritmias, para impedir la muerte cardíaca subita o para influir sobre una contractilidad disminuida del corazon.
ARP990103448A 1998-07-16 1999-07-14 Benzolsulfonilureas y -tioureas 2,5-sustituidas, procedimiento para su preparacion, y preparados farmaceuticos que las contienen AR029305A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19832009A DE19832009A1 (de) 1998-07-16 1998-07-16 2,5-Substituierte Benzolsulfonylharnstoffe und -thioharnstoffe, Verfahren zu ihrer Herstellung, ihre Verwendung und sie enthaltende pharamazeutische Präparate

Publications (1)

Publication Number Publication Date
AR029305A1 true AR029305A1 (es) 2003-06-25

Family

ID=7874296

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990103448A AR029305A1 (es) 1998-07-16 1999-07-14 Benzolsulfonilureas y -tioureas 2,5-sustituidas, procedimiento para su preparacion, y preparados farmaceuticos que las contienen

Country Status (23)

Country Link
US (1) US6410573B1 (es)
EP (1) EP1100775B1 (es)
JP (1) JP4486254B2 (es)
KR (1) KR100979894B1 (es)
CN (1) CN1330632C (es)
AR (1) AR029305A1 (es)
AT (1) ATE256657T1 (es)
AU (1) AU763031B2 (es)
BR (1) BRPI9912125B8 (es)
CA (1) CA2337397C (es)
CZ (1) CZ300828B6 (es)
DE (2) DE19832009A1 (es)
DK (1) DK1100775T3 (es)
ES (1) ES2211126T3 (es)
HK (1) HK1038914B (es)
HU (1) HU227423B1 (es)
ID (1) ID27025A (es)
PL (1) PL194299B1 (es)
PT (1) PT1100775E (es)
RU (1) RU2235720C2 (es)
TR (1) TR200100083T2 (es)
WO (1) WO2000003978A2 (es)
ZA (1) ZA200007691B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19923086A1 (de) 1999-05-20 2000-11-23 Aventis Pharma Gmbh Cinnamoylaminoalkyl-substituierte Benzolsulfonamidderivate, Verfahren zu ihrer Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
DE10054481A1 (de) 2000-11-03 2002-05-08 Aventis Pharma Gmbh Acylaminoalkyl-substituierte Benzolsulfonamidderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
DE10054482A1 (de) * 2000-11-03 2002-05-08 Aventis Pharma Gmbh Heteroarylacryloylaminoalkyl-substituierte Benzolsulfonamidderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
US7618981B2 (en) * 2004-05-06 2009-11-17 Cytokinetics, Inc. Imidazopyridinyl-benzamide anti-cancer agents
DE102004061017A1 (de) * 2004-12-18 2006-06-22 Sanofi-Aventis Deutschland Gmbh Piperidinsulfonylharnstoffe und -thioharnstoffe, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
CN101679191B (zh) * 2007-06-05 2014-03-12 塞诺菲-安万特股份有限公司 二杂芳基环己烷衍生物、其制备方法、用途及含有它们的药用组合物
EP2215065B1 (en) * 2007-10-19 2012-07-11 Boehringer Ingelheim International GmbH Ccr10 antagonists
CN117209366A (zh) * 2022-06-02 2023-12-12 中国石油化工股份有限公司 甲基叔丁基醚精脱硫剂及其脱硫工艺

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE146775T1 (de) * 1993-02-23 1997-01-15 Hoechst Ag Substituierte benzolsulfonylharnstoffe und - thioharnstoffe- verfahren zu ihrer herstellung und ihre verwendung als pharmazeutika
DE4341655A1 (de) * 1993-12-07 1995-06-08 Hoechst Ag Aminosubstituierte Benzolsulfonylharnstoffe und -thioharnstoffe, Verfahren zu ihrer Herstellung und ihre Verwendung als Pharmazeutika
US5631275A (en) 1993-12-30 1997-05-20 Hoechst Aktiengesellschaft Substituted benzenesulfonylureas and -thioureas, preparation processes and possible uses of pharmaceutical preparations based on these compounds
DE4344957A1 (de) 1993-12-30 1995-07-06 Hoechst Ag Substituierte Benzolsulfonylharnstoffe und -thioharnstoffe, Herstellungsverfahren und Verwendungsmöglichkeiten pharmazeutischer Präparate auf Basis dieser Verbindungen
DE19504379A1 (de) 1995-02-10 1996-08-14 Hoechst Ag Substituierte Benzolsulfonylharnstoffe und -thioharnstoffe, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung pharmazeutischer Präparate sowie sie enthaltende pharmazeutische Präparate
DE19505397A1 (de) 1995-02-17 1996-08-22 Hoechst Ag Substituierte Benzolsulfonylharnstoffe und -thioharnstoffe, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
HU226462B1 (en) 1995-02-17 2008-12-29 Hoechst Ag Substituted benzol-sulfonyl-ureas and -thioureas, process for producing them, pharmaceutical compositions containing them, and their use
ZA961314B (en) 1995-02-21 1996-08-27 Hoechst Ag Substituted benzenesulfonylureas and -thioreas processes for their preparation their use for the production of pharmaceutical preparations and medicaments containing them
CZ20002758A3 (cs) * 1999-01-27 2000-12-13 Icagen, Inc. Inhibitory draslíkových kanálů

Also Published As

Publication number Publication date
PT1100775E (pt) 2004-05-31
KR20010074720A (ko) 2001-08-09
CN1330632C (zh) 2007-08-08
CA2337397C (en) 2009-01-13
AU5030799A (en) 2000-02-07
ATE256657T1 (de) 2004-01-15
JP2002520387A (ja) 2002-07-09
JP4486254B2 (ja) 2010-06-23
TR200100083T2 (tr) 2001-06-21
ID27025A (id) 2001-02-22
CA2337397A1 (en) 2000-01-27
ZA200007691B (en) 2002-01-21
DK1100775T3 (da) 2004-04-05
BR9912125A (pt) 2001-04-10
EP1100775B1 (de) 2003-12-17
RU2235720C2 (ru) 2004-09-10
WO2000003978A3 (de) 2000-09-14
BRPI9912125B8 (pt) 2017-03-14
HK1038914B (zh) 2008-01-25
US6410573B1 (en) 2002-06-25
DE59908123D1 (de) 2004-01-29
PL194299B1 (pl) 2007-05-31
AU763031B2 (en) 2003-07-10
KR100979894B1 (ko) 2010-09-06
HU227423B1 (en) 2011-05-30
HK1038914A1 (en) 2002-04-04
ES2211126T3 (es) 2004-07-01
CZ300828B6 (cs) 2009-08-19
HUP0105111A3 (en) 2003-02-28
WO2000003978A2 (de) 2000-01-27
EP1100775A2 (de) 2001-05-23
HUP0105111A1 (hu) 2002-05-29
CZ2001169A3 (en) 2001-05-16
PL345710A1 (en) 2002-01-02
BR9912125B1 (pt) 2013-11-05
CN1314884A (zh) 2001-09-26
DE19832009A1 (de) 2000-01-20

Similar Documents

Publication Publication Date Title
ES2194501T3 (es) Derivados de amidinas, su preparacion, su aplicacion como medicamentos y composiciones farmaceuticas que los contienen.
PH12021550779A1 (en) Sting agonistic compound
UY27892A1 (es) Benzoilureas heterociclicamente sustituidas, procedimiento para su preparacion y su uso como farmacos.
BR0210344A (pt) Inibidores da hiv protease, composições contendo os mesmos, seus usos farmacêuticos e materiais para a sua sìntese
UY28510A1 (es) Compuestos quimicos
ECSP066361A (es) Derivados de piperazina
BR0200982A (pt) Compostos do ácido alfa-amino sulfonila, um processo para sua preparação e composições farmacêuticas compreendendo os mesmos
DK166208C (da) Insekticide pyrazolinderivater og fremgangsmaade til fremstilling deraf, middel indeholdende derivaterne samt derivaternes anvendelse til bekaempelse af insekter og spindemider
MX9704777A (es) Compuestos espiro tetraciclicos, procedimiento para su preparacion y composiciones que los contienen.
AR031430A1 (es) Compuestos de bisarilo orto, meta-sustituidos, procedimientos para su preparacion, su utilizacion como medicamento como tambien los preparados farmaceuticos que los contienen
AR029305A1 (es) Benzolsulfonilureas y -tioureas 2,5-sustituidas, procedimiento para su preparacion, y preparados farmaceuticos que las contienen
CO2025002359A2 (es) Compuestos de pirazolopirimidina y su uso médico
ATE251624T1 (de) Granulatimide-derivate zur behandlung von krebs
PT1345892E (pt) Derivados de benzenossulfonamida substituidos com acilaminoalquilo
MX2025009965A (es) Compuestos sustituidos de pirazolopirimidina y su uso medico
NZ286058A (en) Medicaments comprising quinoxaline derivatives and at least one protease inhibitor
AR048501A1 (es) Compuesto de benzoazabicicloheptano dimerico, composicion farmaceutica que lo comprende y su uso para prepararla
BR0312702A (pt) Derivados de 3-guanidinocarbonil-1-heteroaril-pirrol, processo de preparação e intermediários desse processo, seu uso como medicamentos e composições farmacêuticas compreendendo os mesmos
ES2134928T3 (es) Derivado de benzotiazolsulfonamida, procedimiento de produccion y aplicacion del mismo.
UY28485A1 (es) Compuestos quimicos
UY31118A1 (es) Derivados de di(hetero)arilciclohexano, su preparacion, su uso y composiciones farmaceuticas que los comprenden
ES2054904T3 (es) Procedimiento para la preparacion de peptidos con actividad inhibidora de sistemas enzimaticos.
BRPI0409793A (pt) 4-,6- ou 7-hidroxiindóis com grupos n-óxido e sua aplicação como produtos terapêuticos
BR0010821A (pt) Derivados de benzenossulfonamidas substituìda com cinamoilaminoalquila
EA200400667A2 (ru) Новые соединения бензотиазина и бензотиадиазина, способ их получения и фармацевтические композиции, которые их содержат

Legal Events

Date Code Title Description
FG Grant, registration